These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30744649)

  • 21. Hyperbilirubinemia: current guidelines and emerging therapies.
    Schwartz HP; Haberman BE; Ruddy RM
    Pediatr Emerg Care; 2011 Sep; 27(9):884-9. PubMed ID: 21926893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
    Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
    J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sunlight for the prevention and treatment of hyperbilirubinemia in term and late preterm neonates.
    Horn D; Ehret D; Gautham KS; Soll R
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013277. PubMed ID: 34228352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rates of Extreme Neonatal Hyperbilirubinemia and Kernicterus in Children and Adherence to National Guidelines for Screening, Diagnosis, and Treatment in Sweden.
    Alkén J; Håkansson S; Ekéus C; Gustafson P; Norman M
    JAMA Netw Open; 2019 Mar; 2(3):e190858. PubMed ID: 30901042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the US.
    Pike C; Birnbaum HG; Schiller M; Sharma H; Burge R; Edgell ET
    Pharmacoeconomics; 2010; 28(5):395-409. PubMed ID: 20402541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extreme hyperbilirubinemia and rescue exchange transfusion in California from 2007 to 2012.
    Bhutani VK; Meng NF; Knauer Y; Danielsen BH; Wong RJ; Stevenson DK; Gould JB
    J Perinatol; 2016 Oct; 36(10):853-7. PubMed ID: 27442156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States.
    Lu M; Oladapo A; Wu Y; Farahbakhshian S; Ewenstein B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):175-185. PubMed ID: 33307935
    [No Abstract]   [Full Text] [Related]  

  • 29. Economic and Clinical Burden of Acute Myeloid Leukemia Episodes of Care in the United States: A Retrospective Analysis of a Commercial Payer Database.
    Pandya BJ; Chen CC; Medeiros BC; McGuiness CB; Wilson SD; Walsh EH; Wade RL
    J Manag Care Spec Pharm; 2020 Jul; 26(7):849-859. PubMed ID: 32281456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A single-center experience on exchange transfusion therapy in 123 full-term cases of severe neonatal hyperbilirubinemia in Wuhan.
    Duan L; Gan S; Hu H
    J Matern Fetal Neonatal Med; 2021 Feb; 34(3):466-472. PubMed ID: 33225794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population.
    Lee S; Xie L; Wang Y; Vaidya N; Baser O
    J Manag Care Spec Pharm; 2018 Jul; 24(7):654-663. PubMed ID: 29952710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sn-Mesoporphyrin interdiction of severe hyperbilirubinemia in Jehovah's Witness newborns as an alternative to exchange transfusion.
    Kappas A; Drummond GS; Munson DP; Marshall JR
    Pediatrics; 2001 Dec; 108(6):1374-7. PubMed ID: 11731664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exchange transfusion safety and outcomes in neonatal hyperbilirubinemia.
    Wolf MF; Childers J; Gray KD; Chivily C; Glenn M; Jones L; Kpa M; McMannen T; Reyes I; Zimmerman KO; Clark RH; Greenberg RG
    J Perinatol; 2020 Oct; 40(10):1506-1512. PubMed ID: 32152492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the triage process in neonatal intensive care.
    Zupancic JA; Richardson DK
    Pediatrics; 1998 Dec; 102(6):1432-6. PubMed ID: 9832581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Economic burden of generalized myasthenia gravis (MG) in the United States and the impact of common comorbidities and acute MG-events.
    Zhdanava M; Pesa J; Boonmak P; Cai Q; Pilon D; Choudhry Z; Souayah N
    Curr Med Res Opin; 2024 Jul; 40(7):1145-1153. PubMed ID: 38745448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia.
    Mowitz ME; Mangili A; Han L; Ayyagari R; Gao W; Wang J; Zhao J; Sarda SP
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1117-1125. PubMed ID: 33236680
    [No Abstract]   [Full Text] [Related]  

  • 38. Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks.
    Punaro E; Mezzacappa MA; Facchini FP
    J Pediatr (Rio J); 2011; 87(4):301-6. PubMed ID: 21655685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discharge of newborns with risk factors of severe hyperbilirubinemia: description of a hospital at home-based care monitoring and phototherapy.
    Coquery SS; Georges A; Cortey A; Floch C; Avran D; Gatbois E; Mehler-Jacob C; de Stampa M
    Eur J Pediatr; 2022 Aug; 181(8):3075-3084. PubMed ID: 35695955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
    Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
    Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.